Catalyst Wire Dossier Catalyst Wire Dossier

CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate)

Casein phosphopeptide-amorphous calcium phosphate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate), covering 2012-11-29 to 2012-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy [Phase 2]

See pricing